Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Valneva Announces FDA Suspension Of IXCHIQ License In United States Following Four New Serious Adverse Events Reports

Author: Benzinga Newsdesk | August 25, 2025 01:46am

The suspension of the license is effective immediately and requires Valneva to stop shipping and selling of IXCHIQ® in the United States.

Posted In: VALN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist